Bioluminescence imaging for IL-1β expression in experimental colitis

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Li, Limei ^b,d   Liu, Zhenzhe ^a   Yang, Xinyu ^a   Yan, Huimin ^b   Bao, Shisan ^a,c   Fei, Jian ^a,b  

^a TONGJI UNIVERSITY   (China)

^b Shanghai Research Center for Model Organisms   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DEXTRAN SULFATE; FIREFLY LUCIFERASE; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE IMAGING; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME SPECIFICITY; IMAGING; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

MUS MUSCULUS;

EID: 84875924437     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-16     Document Type: Article

References (30)

1. Challenges in pediatric inflammatory bowel disease. Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Inflamm Bowel Dis 2006 12 885 913 10.1097/01.mib.0000228358. 25364.8b 16954808
2. Inflammatory bowel disease: reviewing an old study under a new perspective. Frangos CC, Frangos CC, Gut 2007 56 1638 1639 17938438
3. Inflammatory bowel diseases: from the mystical to the cellular and now the molecular. Kirsner JB, World J Gastroenterol 2005 11 4127 4128 16156090
4. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Qiu BS, Vallance BA, Blennerhassett PA, Collins SM, Nat Med 1999 5 1178 1182 10.1038/13503 10502822
5. IL-4 exacerbates disease in a Th1 cell transfer model of colitis. Fort M, Lesley R, Davidson N, Menon S, Brombacher F, Leach M, Rennick D, J Immunol 2001 166 2793 2800 11160346
6. TH1-TH2: a procrustean paradigm. Gor DO, Rose NR, Greenspan NS, Nat Immunol 2003 4 503 505 12774069
7. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N, Am J Gastroenterol 2002 97 2820 2828 10.1111/j.1572-0241.2002.07029.x 12425554
8. Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis. Palmen MJ, Dieleman LA, van der Ende MB, Uyterlinde A, Pena AS, Meuwissen SG, van Rees EP, Clin Exp Immunol 1995 99 226 232 7851016
9. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H, Gut 1994 35 669 674 10.1136/gut.35.5.669 8200563
10. The role of interleukin-1 in disease. Dinarello CA, Wolff SM, N Engl J Med 1993 328 106 113 10.1056/NEJM199301143280207 8439348
11. Gp91(phox) contributes to the development of experimental inflammatory bowel disease. Bao S, Carr ED, Xu YH, Hunt NH, Immunol Cell Biol 2011 89 853 860 10.1038/icb.2011.4 21321580
12. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Xu Y, Hunt NH, Bao S, Cell Res 2008 18 1220 1229 10.1038/cr.2008.310 19030026
13. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. O'Neill LA, Greene C, J Leukoc Biol 1998 63 650 657 9620655
14. New horizons in orthopaedic research: elucidation of cellular signal transduction pathways. Roebuck KA, Jacobs JJ, Glant TT, J Bone Joint Surg Am 1999 81 599 602 10360688
15. The protective action of radix Astragalus membranaceus against hapten-induced colitis through modulation of cytokines. Ko JK, Chik CW, Cytokine 2009 47 85 90 10.1016/j.cyto.2009.05.014 19539495
16. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. McAlindon ME, Hawkey CJ, Mahida YR, Gut 1998 42 214 219 10.1136/gut.42.2.214 9536946
17. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, Tilg H, Clin Exp Immunol 2004 138 323 329 10.1111/j.1365-2249.2004.02599.x 15498044
18. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, Thompson RC, Dinarello CA, J Clin Invest 1990 86 972 980 10.1172/JCI114799 2168444
19. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL, Gastroenterology 1989 96 795 803 2914642
20. Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells. Strong SA, Pizarro TT, Klein JS, Cominelli F, Fiocchi C, Gastroenterology 1998 114 1244 1256 10.1016/S0016- 5085(98)70431-7 9609762
21. Mouse models of inflammatory bowel disease. Wirtz S, Neurath MF, Adv Drug Deliv Rev 2007 59 1073 1083 10.1016/j.addr.2007.07.003 17825455
22. The correlation between proinflammatory cytokines, MAdCAM-1 and cellular infiltration in the inflamed colon from TNF-alpha gene knockout mice. Xu Y, Hunt NH, Bao S, Immunol Cell Biol 2007 85 633 639 10.1038/sj.icb.7100112 17768420
23. Elevated interleukin-1beta induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice. Bian MJ, Li LM, Yu M, Fei J, Huang F, Brain Res 2009 1302 256 264 19631617
24. Functional imaging of interleukin 1 beta expression in inflammatory process using bioluminescence imaging in transgenic mice. Li L, Fei Z, Ren J, Sun R, Liu Z, Sheng Z, Wang L, Sun X, Yu J, Wang Z, Fei J, BMC Immunol 2008 9 49 10.1186/1471-2172-9-49 18710581
25. Chemically induced mouse models of intestinal inflammation. Wirtz S, Neufert C, Weigmann B, Neurath MF, Nat Protoc 2007 2 541 546 17406617
26. The effect of restraint stress on experimental colitis is IFN-gamma independent. Xu Y, Hunt NH, Bao S, J Neuroimmunol 2008 200 53 61 10.1016/j.jneuroim.2008.06.008 18662832
27. Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. Martinez-Augustin O, Merlos M, Zarzuelo A, Suarez MD, de Medina FS, BMC Genomics 2008 9 490 10.1186/1471-2164-9-490 18928539
28. Laboratory markers in IBD: useful, magic, or unnecessary toys? Vermeire S, Van Assche G, Rutgeerts P, Gut 2006 55 426 431 10.1136/gut.2005.069476 16474109
29. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D, Gut 1990 31 686 689 10.1136/gut.31.6.686 2379873
30. Fecal microbiota transplantation and emerging applications. Borody TJ, Khoruts A, Nat Rev Gastroenterol Hepatol 2012 9 88 96